---
schema_version: "secwatch.filing_event.v1"
accession: "0001171843-23-001253"
form_type: "8-K"
ticker: "ALHC"
cik: "0001832466"
company_name: "Alignment Healthcare, Inc."
filed_at: "2023-02-28T23:59:59+00:00"
generated_at: "2026-06-18T22:39:49.772204+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Alignment Healthcare reports 2022 revenue of $1.43B, up 23% YoY; guides 2023 revenue $1.705-1.73B

## Summary
- Q4 revenue $361.8M (+21.3% YoY); health plan membership 98,400 (+14.3%).
- Full-year adjusted gross profit $193.6M (13.5% margin); adjusted EBITDA loss $26.7M.
- 2023 guidance: revenue $1.705-1.73B, adjusted gross profit $205-217M, adjusted EBITDA loss $34-20M.
- Beats high end of Q4 and FY2022 guidance on revenue, adjusted gross profit, and adjusted EBITDA.
- Care Anywhere model shows nearly 40% fewer hospitalizations vs. traditional Medicare in all markets.

## SEC filing metadata
- accession: 0001171843-23-001253
- form_type: 8-K
- ticker: ALHC
- cik: 0001832466
- company_name: Alignment Healthcare, Inc.
- filed_at: 2023-02-28T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1832466/000117184323001253/0001171843-23-001253-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1832466/000117184323001253/f8k_022823.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001171843-23-001253
- JSON: https://secwatch.observer/filing/0001171843-23-001253.json
- Plain text: https://secwatch.observer/filing/0001171843-23-001253.txt

## Key facts
- Earnings Releases
  Alignment Healthcare, Inc. reported the fiscal year ended December 31, 2022 results: revenue $1,434.2 million, net income ($149.6) million.
  - Period: the fiscal year ended December 31, 2022
  - Revenue: $1,434.2 million
  - Net income: ($149.6) million
  - Result: reported results
  source text: Total revenue was $1,434.2 million, up 22.8% year over year Health plan premium revenue of $1,372.3 million represented 22.4% growth year over year Adjusted gross profit was $193.6 million and loss from operations was ($128.6) million Adjusted gross profit excludes depreciation and amortization of $17.5 million and selling, general, and administrative expenses of $295.6 million (which includes $72.6 million of equity-based compensation). Adjusted gross profit also excludes an additional $9.1 million of equity-based compensation recorded within medical expenses Medical benefits ratio based on adjusted gross profit was 86.5% Adjusted EBITDA was ($26.7) million and net loss was ($149.6) million
  evidence_url: https://www.sec.gov/Archives/edgar/data/1832466/000117184323001253/0001171843-23-001253-index.htm
- Earnings Releases
  Alignment Healthcare, Inc. reported the three months ending March 31, 2023 and the fiscal year ending December 31, 2023 results: revenue $429 $434 $1,705 $1,730. Guidance initiated.
  - Period: the three months ending March 31, 2023 and the fiscal year ending December 31, 2023
  - Revenue: $429 $434 $1,705 $1,730
  - Guidance: initiated
  - Result: guidance update
  source text: Revenue $429 $434 $1,705 $1,730 Adjusted Gross Profit 1 $38 $41 $205 $217 Adjusted EBITDA 2 ($17) ($14) ($34) ($20)
  evidence_url: https://www.sec.gov/Archives/edgar/data/1832466/000117184323001253/0001171843-23-001253-index.htm
- Earnings Releases
  Alignment Healthcare, Inc. reported the fourth quarter ended December 31, 2022 results: revenue $361.8 million, net income ($57.0) million.
  - Period: the fourth quarter ended December 31, 2022
  - Revenue: $361.8 million
  - Net income: ($57.0) million
  - Result: reported results
  source text: Total revenue was $361.8 million, up 21.3% year over year Health plan premium revenue of $344.9 million represented 21.5% growth year over year Adjusted gross profit was $38.3 million and loss from operations was ($52.1) million Adjusted gross profit excludes depreciation and amortization of $4.8 million and selling, general, and administrative expenses of $83.2 million (which includes $20.5 million of equity-based compensation). Adjusted gross profit also excludes an additional $2.4 million of equity-based compensation recorded within medical expenses Medical benefits ratio based on adjusted gross profit was 89.4% Adjusted EBITDA was ($23.7) million and net loss was ($57.0) million
  evidence_url: https://www.sec.gov/Archives/edgar/data/1832466/000117184323001253/0001171843-23-001253-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.